Nomograms for predicting survival in patients with HER2 negative breast cancer.

被引：0
|
作者：
Xu, Yiyue [1 ]
Zou, Bing [1 ]
Fan, Bingjie [1 ]
Li, Butuo [1 ]
Wang, Linlin [1 ]
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Dept Radiat Oncol, Shandong Canc Hosp & Inst, Jinan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12528
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Luminal (Her2 negative) prognostic index and survival of breast cancer patients
    Chen, Xuesong
    Cong, Yingying
    Pan, Lihua
    Jiang, Ying
    Meng, Qingwei
    Sun, Lichun
    Pang, Hui
    Zhao, Yanbin
    Dong, Xiaoqun
    Cai, Li
    [J]. CANCER EPIDEMIOLOGY, 2014, 38 (03) : 286 - 290
  • [2] Development of nomograms including HER2 status for predicting survival in metastatic gastric cancer
    Narita, Y.
    Kadowaki, S.
    Oze, I.
    Taniguchi, H.
    Ura, T.
    Ando, M.
    Ito, S.
    Yatabe, Y.
    Tajika, M.
    Muro, K.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 61 - 62
  • [3] Prospective Validation and Characterization of HER2 Positive Circulating Tumor Cells in Patients with HER2 Negative Metastatic Breast Cancer.
    Olson, E. M.
    Flores, L. M.
    Najita, J. S.
    Curley, C.
    Jeong, J.
    Murray, K.
    Savoie, J. J.
    Winer, E. P.
    Krop, I. E.
    [J]. CANCER RESEARCH, 2011, 71
  • [4] TOP2A mRNA expression in HER2 negative breast cancer.
    Gennari, A.
    Sormani, M.
    Pfeffer, U.
    Morandi, L.
    Mustacchi, G.
    Danesi, R.
    Mirisola, V
    Bruzzi, P.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 357S - 357S
  • [5] A nomogram for predicting the HER2 status of circulating tumor cells and survival analysis in HER2-negative breast cancer
    Yang, Yuqin
    Li, Liudan
    Tian, Wenjing
    Qiao, Zhen
    Qin, Qi
    Su, Liqian
    Li, Peiqiu
    Chen, Weirong
    Zhao, Hong
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer
    Yaping Yang
    Ying Wang
    Heran Deng
    Cui Tan
    Qian Li
    Zhanghai He
    Wei Wei
    Enxiang Zhou
    Qiang Liu
    Jieqiong Liu
    [J]. BMC Cancer, 19
  • [7] Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer
    Yang, Yaping
    Wang, Ying
    Deng, Heran
    Tan, Cui
    Li, Qian
    He, Zhanghai
    Wei, Wei
    Zhou, Enxiang
    Liu, Qiang
    Liu, Jieqiong
    [J]. BMC CANCER, 2019, 19 (1)
  • [8] HER2 overexpressing metastatic breast cancer.
    Spigel D.R.
    Burstein H.J.
    [J]. Current Treatment Options in Oncology, 2002, 3 (2) : 163 - 174
  • [9] Disparities in HER2 testing in breast cancer.
    Paryani, Vijay
    Schroeder, Mary Chen
    Klepin, Heidi D.
    Melin, Susan Anitra
    Russell, Greg B.
    Winkfield, Karen Marie
    Thomas, Alexandra
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Establishment of Prognostic Nomograms for Predicting the Survival of HR-Positive, HER2-Negative Metastatic Breast Cancer Patients Treated with Everolimus
    Duan, Fangfang
    Song, Chenge
    Ma, Yuyu
    Jiang, Kuikui
    Xu, Fei
    Bi, Xiwen
    Huang, Jiajia
    Hong, Ruoxi
    Huang, Zhangzan
    Lu, Qianyi
    Yuan, Zhongyu
    Wang, Shusen
    Xia, Wen
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 3463 - 3473
12345